{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:53:54Z","timestamp":1763765634716},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1309\/m1ec8je9acamjacu","type":"journal-article","created":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T16:20:34Z","timestamp":1175271634000},"page":"89-96","source":"Crossref","is-referenced-by-count":58,"title":["Molecular Analysis of c-<i>Kit<\/i>and<i>PDGFRA<\/i>in GISTs Diagnosed by EUS"],"prefix":"10.1093","volume":"127","author":[{"given":"Ana L.","family":"Gomes","sequence":"first","affiliation":[]},{"given":"Ricardo H.","family":"Bardales","sequence":"additional","affiliation":[]},{"given":"Fernanda","family":"Milanezi","sequence":"additional","affiliation":[]},{"given":"Rui M.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2007,1,1]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Rubin BP. Gastrointestinal stromal tumours: an update. <i>Histopathology.<\/i> 2006;48:83-96.","DOI":"10.1111\/j.1365-2559.2005.02291.x"},{"key":"E00002","unstructured":"Joensuu H, Kindblom LG. Gastrointestinal stromal tumors: a review. <i>Acta Orthop Scand Suppl.<\/i> 2004;75:62-71."},{"key":"E00003","unstructured":"Corless CL, McGreevey L, Haley A, et al. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. <i>Am J Pathol.<\/i> 2002;160:1567-1572."},{"key":"E00004","unstructured":"Carter TA, Wodicka LM, Shah NP, et al. Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. <i>Proc Natl Acad Sci U S A.<\/i> 2005;102:11011-11016."},{"key":"E00005","unstructured":"Fu K, Eloubeidi MA, Jhala NC, et al. Diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound\u2014guided fine needle aspiration biopsy: a potential pitfall. <i>Ann Diagn Pathol.<\/i> 2002;6:294-301."},{"key":"E00006","unstructured":"Willmore-Payne C, Layfield LJ, Holden JA. c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens. <i>Cancer.<\/i> 2005;105:165-170."},{"key":"E00007","unstructured":"Padilla C, Saez A, Vidal A, et al. Fine-needle aspiration cytology diagnosis of metastatic gastrointestinal stromal tumor in the liver: a report of three cases. <i>Diagn Cytopathol.<\/i> 2002;27:298-302."},{"key":"E00008","unstructured":"Monihan JM, Carr NJ, Sobin LH. CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses. <i>Histopathology.<\/i> 1994;25:469-473."},{"key":"E00009","unstructured":"Miettinen M, Virolainen M, Maarit SR. Gastrointestinal stromal tumors: value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. <i>Am J Surg Pathol.<\/i> 1995;19:207-216."},{"key":"E00010","unstructured":"Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. <i>Science.<\/i> 1998;279:577-580."},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Hirota S. Gastrointestinal stromal tumors: their origin and cause. <i>Int J Clin Oncol.<\/i> 2001;6:1-5.","DOI":"10.1007\/PL00012072"},{"key":"E00012","unstructured":"Kitamura Y, Hirotab S. Kit as a human oncogenic tyrosine kinase. <i>Cell Mol Life Sci.<\/i> 2004;61:2924-2931."},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Ronnstrand L. Signal transduction via the stem cell factor receptor\/c-Kit. <i>Cell Mol Life Sci.<\/i> 2004;61:2535-2548.","DOI":"10.1007\/s00018-004-4189-6"},{"key":"E00014","unstructured":"Roskoski R Jr. Structure and regulation of Kit protein\u2014tyrosine kinase: the stem cell factor receptor. <i>Biochem Biophys Res Commun.<\/i> 2005;338:1307-1315."},{"key":"E00015","unstructured":"Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. <i>Hum Pathol.<\/i> 1998;29:498-504."},{"key":"E00016","unstructured":"Looijenga LH, de Leeuw H, van Oorschot M, et al. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. <i>Cancer Res.<\/i> 2003;63:7674-7678."},{"key":"E00017","unstructured":"Rossi G, Cavazza A, Marchioni A, et al. Kit expression in small cell carcinomas of the lung: effects of chemotherapy. <i>Mod Pathol.<\/i> 2003;16:1041-1047."},{"key":"E00018","unstructured":"Crosier PS, Ricciardi ST, Hall LR, et al. Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. <i>Blood.<\/i> 1993;82:1151-1158."},{"key":"E00019","unstructured":"Uccini S, Mannarino O, McDowell HP, et al. Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors. <i>Clin Cancer Res.<\/i> 2005;11:380-389."},{"key":"E00020","unstructured":"Montone KT, van Belle P, Elenitsas R, et al. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression. <i>Mod Pathol.<\/i> 1997;10:939-944."},{"key":"E00021","unstructured":"Raspollini MR, Amunni G, Villanucci A, et al. c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study. <i>Ann Oncol.<\/i> 2004;15:594-597."},{"key":"E00022","unstructured":"Ulivi P, Zoli W, Medri L, et al. c-kit and SCF expression in normal and tumor breast tissue. <i>Breast Cancer Res Treat.<\/i> 2004;83:33-42."},{"key":"E00023","unstructured":"Debiec-Rychter M, Dumez H, Judson I, et al. Use of c-KIT\/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group. <i>Eur J Cancer.<\/i> 2004;40:689-695."},{"key":"E00024","unstructured":"Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. <i>Science.<\/i> 2003;299:708-710."},{"key":"E00025","unstructured":"Blay JY, Bonvalot S, Casali P, et al. Consensus meeting for the management of gastrointestinal stromal tumors: report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. <i>Ann Oncol.<\/i> 2005;16:566-578."},{"key":"E00026","unstructured":"Baker DE. Imatinib mesylate. <i>Rev Gastroenterol Disord.<\/i> 2002;2:75-86."},{"key":"E00027","unstructured":"Tarn C, Merkel E, Canutescu AA, et al. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. <i>Clin Cancer Res.<\/i> 2005;11:3668-3677."},{"key":"E00028","unstructured":"Wilson J, Connock M, Song F, et al. Imatinib for the treatment of patients with unresectable and\/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation. <i>Health Technol Assess.<\/i> 2005;9:1-142."},{"key":"E00029","unstructured":"US Food and Drug Administration. FDA approves new treatment for gastrointestinal and kidney cancer [press release]. Rockville, MD: FDA; January 26, 2006. Available at: <a target=\"_blank\" href='http:\/\/www.fda.gov\/bbs\/topics\/news\/2006\/NEW01302.html'>http:\/\/www.fda.gov\/bbs\/topics\/news\/2006\/NEW01302.html<\/a>"},{"key":"E00030","unstructured":"Chhieng DC, Jhala D, Jhala N, et al. Endoscopic ultrasound\u2014guided fine-needle aspiration biopsy: a study of 103 cases. <i>Cancer.<\/i> 2002;96:232-239."},{"key":"E00031","unstructured":"Bardales RH, Stelow EB, Mallery S, et al. Review of endoscopic ultrasound\u2014guided fine-needle aspiration cytology. <i>Diagn Cytopathol.<\/i> 2006;34:140-175."},{"key":"E00032","unstructured":"Vander NM III, Eloubeidi MA, Chen VK, et al. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound\u2014guided fine-needle aspiration biopsy. <i>Cancer.<\/i> 2004;102:157-163."},{"key":"E00033","unstructured":"Stelow EB, Stanley MW, Mallery S, et al. Endoscopic ultrasound\u2014guided fine-needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. <i>Am J Clin Pathol.<\/i> 2003;119:703-708."},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"Carvalho I, Milanezi F, Martins A, et al. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. <i>Breast Cancer Res.<\/i> 2005;7:R788-R795.","DOI":"10.1186\/bcr1304"},{"key":"E00035","unstructured":"Reis RM, Martins A, Ribeiro SA, et al. Molecular characterization of PDGFR-alpha\/PDGF-A and c-KIT\/SCF in gliosarcomas. <i>Cell Oncol.<\/i> 2005;27:319-326."},{"key":"E00036","unstructured":"Heinrich MC, Corless CL, Demetri GD, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. <i>J Clin Oncol.<\/i> 2003;21:4342-4349."},{"key":"E00037","unstructured":"Zalcberg JR, Verweij J, Casali PG, et al. Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. <i>Eur J Cancer.<\/i> 2005;41:1751-1757."},{"key":"E00038","unstructured":"Morey AL, Wanigesekera GD, Hawkins NJ, et al. C-kit mutations in gastrointestinal stromal tumours. <i>Pathology.<\/i> 2002;34:315-319."},{"key":"E00039","unstructured":"Wasag B, Debiec-Rychter M, Pauwels P, et al. Differential expression of KIT\/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site. <i>Mod Pathol.<\/i> 2004;17:889-894."},{"key":"E00040","unstructured":"Wardelmann E, Losen I, Hans V, et al. Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors. <i>Int J Cancer.<\/i> 2003;106:887-895."},{"key":"E00041","unstructured":"Wardelmann E, Merkelbach-Bruse S, Pauls K, et al. Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate. <i>Clin Cancer Res.<\/i> 2006;12:1743-1749."},{"key":"E00042","unstructured":"Frost MJ, Ferrao PT, Hughes TP, et al. Juxtamembrane mutant V560GK it is more sensitive to imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816V Kit is resistant. <i>Mol Cancer Ther.<\/i> 2002;1:1115-1124."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/127\/1\/89\/4988704\/ajcpath127-0089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T19:14:27Z","timestamp":1556306067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/M1EC8JE9ACAMJACU"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,1,1]]},"published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.1309\/M1EC8JE9ACAMJACU"],"URL":"https:\/\/doi.org\/10.1309\/m1ec8je9acamjacu","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}